Read, discover and understand progress, achievements and outcomes of cancer research, education and clinical care delivered by the VCCC, our alliance members, supporters and partners.
This week many of you will have celebrated the success of friends and colleagues who were awarded an Australia Day honour.
Dr Belinda Yeo and Professor Bruce Mann have been appointed joint VCCC Research & Education Leads – Breast Cancer
The Research & Education Lead program is key to the VCCC’s endeavours to systematise collaboration across the alliance, and pivotal to turning the idea of integration of research, education and clinical care, into reality.
Many smokers are wary of going to the doctor when they develop respiratory symptoms, because they’re worried about getting ticked off for being a smoker in the first place.
That’s especially problematic because catching lung cancer early is key.
So how can health bodies get those at risk to see a doc earlier?
Projects target functional, physical, social and emotional challenges that accompany a diagnosis of cancer
Throughout her career, Professor Mei Krishnasamy has worked to improve the evidence base for cancer nursing care, particularly for people with rarer cancers.
Deaths rates from rectal cancer are predicted to increase almost 60 per cent in Australia by 2035, while many other countries are seeing death rates fall.
On the plus side, Australia's rates of colon cancer are expected to fall by around 50 per cent by 2035. Death rates for both colon and rectal cancer are expected to drop globally but the total number of deaths is expected to rise, due to population growth and ageing.
Capitalising on digital health technology
Patients with cancer living in regional and rural Victoria will soon have access to clinical trials, on their doorstep.
Range of initiatives now underway
Increasing clinical trials harmonisation and enhancing capability across alliance partner trial sites are key initiatives to improve benefits to patients and access to cancer clinical trials.
Imperative that the conference provides innovative content that reflects the breadth and depth of our partners and collaborators
The VCCC Research Conference provides a spotlight for Victorian cancer research discoveries, education achievements and clinical translation outcomes, as well as bringing together national and international experts.
I’m very pleased to wrap up the year with the news that the first cancer clinical trial implemented through the VCCC Teletrials Program has opened in Albury, Wodonga and Bendigo.
Helping Cancer Researchers Pinpoint The Issue
The Australian Cancer Research Foundation (ACRF) Translational Proteomic Facility is the first in Australia with the capability for protein-based assays that will complement the use of genomics in targeting cancer therapies.
The Victorian Comprehensive Cancer Centre alliance with the University of Melbourne is coordinating a new Master of Cancer Sciences
Course coordinator Dr David Kok, Radiation Oncologist, Peter MacCallum Cancer Centre shares his passion for the new educational program with researcher and potential student Helen Sehric.
New program to explore opportunities and collaborations
On Thursday 25 October, the Building Capability in Clinical Trials Program was kick-started at the Parkville Integrated Palliative Care Service.
Congratulations to 200th CCPhD student Narelle Keating
Last month the 200th student - Narelle Keating enrolled in the program, signifying a major milestone in networking and information sharing among emerging cancer researchers.
Last week I attended the inaugural Advances in Cancer Drug Discovery and Development Symposium, jointly presented by Cancer Therapeutics CRC - (CTx), Merck Sharpe and Dohme MSD,and the Victorian Comprehensive Cancer Centre alliance.
As I was preparing to attend the World Cancer Congress last week I was struck by the authenticity and relevance of a speech happening at another world forum.
As Australia’s only fully-fledged comprehensive cancer centre, our distributed leadership model is essential to a community that crosses institutional, organisation and expertise boundaries.
A new collaborative Centre for Cancer Immunotherapy
The Victorian Comprehensive Cancer Centre alliance, Peter MacCallum Cancer Centre and the University of Melbourne have partnered to create a new collaborative Centre for Cancer Immunotherapy.
We are delighted to announce the appointment of Dr Anna Boltong to the key leadership position of Associate Director
As the VCCC alliance accelerates efforts to deliver its $30 million Strategic Research Plan by 2020, we are delighted to announce the appointment of Dr Anna Boltong to the key leadership position of Associate Director. This is a pivotal role providing strategic and operational oversight across the VCCC’s main portfolio areas, with particular focus on program quality and long-term sustainability.
The VCCC Consumer Engagement Action Plan will provide a comprehensive model and implementation plan to guide our efforts in this area. It draws on the Cancer Australia National Framework for Consumer Involvement in Cancer Control.
Investigator-initiated trials broaden opportunities and benefits to patients
The Victorian Comprehensive Cancer Centre’s first Investigator-Initiated Trial Capacity Building support package has been awarded to Professor Geoff Lindeman.
The next generation of cancer research has been given a boost with three VCCC PhD students receiving this year’s Picchi Awards for Excellence in Cancer Research at an award ceremony on 9 July.
It has been inspiring to see so many partner organisations and individuals recognised with a variety of prestigious awards and accolades in the past month or so.
Immunotherapy is very much on the mainstream agenda this week as I return from the American Society of Clinical Oncology (ASCO) annual meeting, with a number of headline stories making the news internationally.
Announcing five new VCCC Research & Education Lead
A foundation principle of the Victorian Comprehensive Cancer Centre (VCCC) is that, as an alliance, we are greater than the sum of our parts. Translating this into real-world practicality requires more than traditional collaboration. It demands strong, collegiate leadership and strategic, systematised ways of working across organisational boundaries and disciplines.
What if there was a new approach to clinical trials that addressed pragmatic clinical questions and was far more cost effective than traditional clinical trials?
And what if these trials could be conducted using ‘real world’ patients, rather than the selective populations often used in conventional clinical trials, thereby providing answers that could be readily applied to everyday clinical settings?